Loading…

High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran

In the last months of 2019, an outbreak of fatal respiratory disease started in Wuhan, China, and quickly spread to other parts of the world. It was named COVID‐19, and to date, thousands of cases of infection and death are reported worldwide. This disease is associated with a wide range of symptoms...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical virology 2021-02, Vol.93 (2), p.1008-1012
Main Authors: Hashemi, Seyed A., Safamanesh, Saghar, Ghasemzadeh‐moghaddam, Hamed, Ghafouri, Majid, Azimian, Amir
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803
cites cdi_FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803
container_end_page 1012
container_issue 2
container_start_page 1008
container_title Journal of medical virology
container_volume 93
creator Hashemi, Seyed A.
Safamanesh, Saghar
Ghasemzadeh‐moghaddam, Hamed
Ghafouri, Majid
Azimian, Amir
description In the last months of 2019, an outbreak of fatal respiratory disease started in Wuhan, China, and quickly spread to other parts of the world. It was named COVID‐19, and to date, thousands of cases of infection and death are reported worldwide. This disease is associated with a wide range of symptoms, which makes accurate diagnosis of it difficult. During previous severe acute respiratory syndrome (SARS) pandemic in 2003, researchers found that the patients with fever, cough, or sore throat had a 5% influenza virus‐positive rate. This finding made us think that the wide range of symptoms and also relatively high prevalence of death in our patients may be due to the coinfection with other viruses. Thus, we evaluated the coinfection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with other respiratory viruses in dead patients in North Khorasan. We evaluated the presence of influenza A/B virus, human metapneumovirus, bocavirus, adenovirus, respiratory syncytial virus (RSV), and parainfluenza viruses in 105 SARS‐CoV‐2 positive dead patients, using polymerase chain reaction (PCR) and reverse transcription PCR tests. We found coinfection with influenza virus in 22.3%, RSV, and bocavirus in 9.7%, parainfluenza viruses in 3.9%, human metapneumovirus in 2.9%, and finally adenovirus in 1.9% of SARS‐CoV‐2 positive dead cases. Our findings highlight a high prevalence of coinfection with influenza A virus and the monopoly of coinfection with Human metapneumovirus in children. Highlights The high prevalence of SARS‐CoV‐2 and influenza co‐infection can lead to an increase of death in patients and mislead the treatment protocols.
doi_str_mv 10.1002/jmv.26364
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2428059704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2428059704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803</originalsourceid><addsrcrecordid>eNp10c1O3DAUBWCrAsEwZdEXqCx1A4vAteNJ7OVoRJlBQKXys40c56ZklLGDnUxFV30EnpEnwTDQRSU2tmR_Orq6h5AvDI4YAD9ertZHPEsz8YmMGKgsUZCzLTICJrIky9hkl-yFsAQAqTjfIbspzznkkI5IN29-3dHO41q3aA1SV9Or6c-rp7-PM3cbT061rWhj63ZA-0fTKV03fgj0YM4u2SE1Ln6h6RtnI6IV6op2um_Q9uHl4dL5_g516NFbuvDafibbtW4D7r_dY3Lz_eR6Nk_Of5wuZtPzxKRSioSVgGnORC0UQ2RxWDNRKheiqmUlcxC8FBOFWVVCZVCouuQsNSZDpmVeS0jH5GCT23l3P2Doi1UTDLattuiGUHDBJUxUTIr023906QZv43RR5amMK5YyqsONMt6F4LEuOt-stH8oGBQvNRSxhuK1hmi_viUO5Qqrf_J97xEcb8DvpsWHj5OKs4vbTeQzOkGQ7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473800288</pqid></control><display><type>article</type><title>High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Hashemi, Seyed A. ; Safamanesh, Saghar ; Ghasemzadeh‐moghaddam, Hamed ; Ghafouri, Majid ; Azimian, Amir</creator><creatorcontrib>Hashemi, Seyed A. ; Safamanesh, Saghar ; Ghasemzadeh‐moghaddam, Hamed ; Ghafouri, Majid ; Azimian, Amir</creatorcontrib><description>In the last months of 2019, an outbreak of fatal respiratory disease started in Wuhan, China, and quickly spread to other parts of the world. It was named COVID‐19, and to date, thousands of cases of infection and death are reported worldwide. This disease is associated with a wide range of symptoms, which makes accurate diagnosis of it difficult. During previous severe acute respiratory syndrome (SARS) pandemic in 2003, researchers found that the patients with fever, cough, or sore throat had a 5% influenza virus‐positive rate. This finding made us think that the wide range of symptoms and also relatively high prevalence of death in our patients may be due to the coinfection with other viruses. Thus, we evaluated the coinfection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with other respiratory viruses in dead patients in North Khorasan. We evaluated the presence of influenza A/B virus, human metapneumovirus, bocavirus, adenovirus, respiratory syncytial virus (RSV), and parainfluenza viruses in 105 SARS‐CoV‐2 positive dead patients, using polymerase chain reaction (PCR) and reverse transcription PCR tests. We found coinfection with influenza virus in 22.3%, RSV, and bocavirus in 9.7%, parainfluenza viruses in 3.9%, human metapneumovirus in 2.9%, and finally adenovirus in 1.9% of SARS‐CoV‐2 positive dead cases. Our findings highlight a high prevalence of coinfection with influenza A virus and the monopoly of coinfection with Human metapneumovirus in children. Highlights The high prevalence of SARS‐CoV‐2 and influenza co‐infection can lead to an increase of death in patients and mislead the treatment protocols.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.26364</identifier><identifier>PMID: 32720703</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>adenovirus ; Adenoviruses ; Adolescent ; Adult ; bocavirus ; Cadaver ; Child ; Child, Preschool ; China - epidemiology ; coinfection ; Coinfection - epidemiology ; Coinfection - mortality ; Coinfection - virology ; Coronaviruses ; Cough ; COVID-19 ; COVID-19 - epidemiology ; Death ; Female ; Fever ; human metapneumovirus ; Humans ; Infant ; Infant, Newborn ; Infections ; Influenza ; Influenza A ; influenza virus ; Influenza, Human - epidemiology ; Iran - epidemiology ; Male ; Middle Aged ; Mortality ; Orthomyxoviridae - isolation &amp; purification ; Pandemics ; Parainfluenza ; parainfluenza virus ; Pharyngitis ; Polymerase chain reaction ; Prevalence ; Public health ; Respiratory diseases ; Respiratory syncytial virus ; Respiratory Syncytial Virus, Human - isolation &amp; purification ; Reverse transcription ; SARS-CoV-2 - isolation &amp; purification ; SARS‐Cov‐2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Signs and symptoms ; Viral diseases ; Virology ; Viruses ; Viruses - classification ; Viruses - isolation &amp; purification ; Young Adult</subject><ispartof>Journal of medical virology, 2021-02, Vol.93 (2), p.1008-1012</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803</citedby><cites>FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803</cites><orcidid>0000-0002-2532-8198</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32720703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashemi, Seyed A.</creatorcontrib><creatorcontrib>Safamanesh, Saghar</creatorcontrib><creatorcontrib>Ghasemzadeh‐moghaddam, Hamed</creatorcontrib><creatorcontrib>Ghafouri, Majid</creatorcontrib><creatorcontrib>Azimian, Amir</creatorcontrib><title>High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>In the last months of 2019, an outbreak of fatal respiratory disease started in Wuhan, China, and quickly spread to other parts of the world. It was named COVID‐19, and to date, thousands of cases of infection and death are reported worldwide. This disease is associated with a wide range of symptoms, which makes accurate diagnosis of it difficult. During previous severe acute respiratory syndrome (SARS) pandemic in 2003, researchers found that the patients with fever, cough, or sore throat had a 5% influenza virus‐positive rate. This finding made us think that the wide range of symptoms and also relatively high prevalence of death in our patients may be due to the coinfection with other viruses. Thus, we evaluated the coinfection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with other respiratory viruses in dead patients in North Khorasan. We evaluated the presence of influenza A/B virus, human metapneumovirus, bocavirus, adenovirus, respiratory syncytial virus (RSV), and parainfluenza viruses in 105 SARS‐CoV‐2 positive dead patients, using polymerase chain reaction (PCR) and reverse transcription PCR tests. We found coinfection with influenza virus in 22.3%, RSV, and bocavirus in 9.7%, parainfluenza viruses in 3.9%, human metapneumovirus in 2.9%, and finally adenovirus in 1.9% of SARS‐CoV‐2 positive dead cases. Our findings highlight a high prevalence of coinfection with influenza A virus and the monopoly of coinfection with Human metapneumovirus in children. Highlights The high prevalence of SARS‐CoV‐2 and influenza co‐infection can lead to an increase of death in patients and mislead the treatment protocols.</description><subject>adenovirus</subject><subject>Adenoviruses</subject><subject>Adolescent</subject><subject>Adult</subject><subject>bocavirus</subject><subject>Cadaver</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>China - epidemiology</subject><subject>coinfection</subject><subject>Coinfection - epidemiology</subject><subject>Coinfection - mortality</subject><subject>Coinfection - virology</subject><subject>Coronaviruses</subject><subject>Cough</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>Death</subject><subject>Female</subject><subject>Fever</subject><subject>human metapneumovirus</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>influenza virus</subject><subject>Influenza, Human - epidemiology</subject><subject>Iran - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Orthomyxoviridae - isolation &amp; purification</subject><subject>Pandemics</subject><subject>Parainfluenza</subject><subject>parainfluenza virus</subject><subject>Pharyngitis</subject><subject>Polymerase chain reaction</subject><subject>Prevalence</subject><subject>Public health</subject><subject>Respiratory diseases</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory Syncytial Virus, Human - isolation &amp; purification</subject><subject>Reverse transcription</subject><subject>SARS-CoV-2 - isolation &amp; purification</subject><subject>SARS‐Cov‐2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signs and symptoms</subject><subject>Viral diseases</subject><subject>Virology</subject><subject>Viruses</subject><subject>Viruses - classification</subject><subject>Viruses - isolation &amp; purification</subject><subject>Young Adult</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp10c1O3DAUBWCrAsEwZdEXqCx1A4vAteNJ7OVoRJlBQKXys40c56ZklLGDnUxFV30EnpEnwTDQRSU2tmR_Orq6h5AvDI4YAD9ertZHPEsz8YmMGKgsUZCzLTICJrIky9hkl-yFsAQAqTjfIbspzznkkI5IN29-3dHO41q3aA1SV9Or6c-rp7-PM3cbT061rWhj63ZA-0fTKV03fgj0YM4u2SE1Ln6h6RtnI6IV6op2um_Q9uHl4dL5_g516NFbuvDafibbtW4D7r_dY3Lz_eR6Nk_Of5wuZtPzxKRSioSVgGnORC0UQ2RxWDNRKheiqmUlcxC8FBOFWVVCZVCouuQsNSZDpmVeS0jH5GCT23l3P2Doi1UTDLattuiGUHDBJUxUTIr023906QZv43RR5amMK5YyqsONMt6F4LEuOt-stH8oGBQvNRSxhuK1hmi_viUO5Qqrf_J97xEcb8DvpsWHj5OKs4vbTeQzOkGQ7A</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Hashemi, Seyed A.</creator><creator>Safamanesh, Saghar</creator><creator>Ghasemzadeh‐moghaddam, Hamed</creator><creator>Ghafouri, Majid</creator><creator>Azimian, Amir</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2532-8198</orcidid></search><sort><creationdate>202102</creationdate><title>High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran</title><author>Hashemi, Seyed A. ; Safamanesh, Saghar ; Ghasemzadeh‐moghaddam, Hamed ; Ghafouri, Majid ; Azimian, Amir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adenovirus</topic><topic>Adenoviruses</topic><topic>Adolescent</topic><topic>Adult</topic><topic>bocavirus</topic><topic>Cadaver</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>China - epidemiology</topic><topic>coinfection</topic><topic>Coinfection - epidemiology</topic><topic>Coinfection - mortality</topic><topic>Coinfection - virology</topic><topic>Coronaviruses</topic><topic>Cough</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>Death</topic><topic>Female</topic><topic>Fever</topic><topic>human metapneumovirus</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>influenza virus</topic><topic>Influenza, Human - epidemiology</topic><topic>Iran - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Orthomyxoviridae - isolation &amp; purification</topic><topic>Pandemics</topic><topic>Parainfluenza</topic><topic>parainfluenza virus</topic><topic>Pharyngitis</topic><topic>Polymerase chain reaction</topic><topic>Prevalence</topic><topic>Public health</topic><topic>Respiratory diseases</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory Syncytial Virus, Human - isolation &amp; purification</topic><topic>Reverse transcription</topic><topic>SARS-CoV-2 - isolation &amp; purification</topic><topic>SARS‐Cov‐2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signs and symptoms</topic><topic>Viral diseases</topic><topic>Virology</topic><topic>Viruses</topic><topic>Viruses - classification</topic><topic>Viruses - isolation &amp; purification</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashemi, Seyed A.</creatorcontrib><creatorcontrib>Safamanesh, Saghar</creatorcontrib><creatorcontrib>Ghasemzadeh‐moghaddam, Hamed</creatorcontrib><creatorcontrib>Ghafouri, Majid</creatorcontrib><creatorcontrib>Azimian, Amir</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashemi, Seyed A.</au><au>Safamanesh, Saghar</au><au>Ghasemzadeh‐moghaddam, Hamed</au><au>Ghafouri, Majid</au><au>Azimian, Amir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>93</volume><issue>2</issue><spage>1008</spage><epage>1012</epage><pages>1008-1012</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>In the last months of 2019, an outbreak of fatal respiratory disease started in Wuhan, China, and quickly spread to other parts of the world. It was named COVID‐19, and to date, thousands of cases of infection and death are reported worldwide. This disease is associated with a wide range of symptoms, which makes accurate diagnosis of it difficult. During previous severe acute respiratory syndrome (SARS) pandemic in 2003, researchers found that the patients with fever, cough, or sore throat had a 5% influenza virus‐positive rate. This finding made us think that the wide range of symptoms and also relatively high prevalence of death in our patients may be due to the coinfection with other viruses. Thus, we evaluated the coinfection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with other respiratory viruses in dead patients in North Khorasan. We evaluated the presence of influenza A/B virus, human metapneumovirus, bocavirus, adenovirus, respiratory syncytial virus (RSV), and parainfluenza viruses in 105 SARS‐CoV‐2 positive dead patients, using polymerase chain reaction (PCR) and reverse transcription PCR tests. We found coinfection with influenza virus in 22.3%, RSV, and bocavirus in 9.7%, parainfluenza viruses in 3.9%, human metapneumovirus in 2.9%, and finally adenovirus in 1.9% of SARS‐CoV‐2 positive dead cases. Our findings highlight a high prevalence of coinfection with influenza A virus and the monopoly of coinfection with Human metapneumovirus in children. Highlights The high prevalence of SARS‐CoV‐2 and influenza co‐infection can lead to an increase of death in patients and mislead the treatment protocols.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32720703</pmid><doi>10.1002/jmv.26364</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-2532-8198</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2021-02, Vol.93 (2), p.1008-1012
issn 0146-6615
1096-9071
language eng
recordid cdi_proquest_miscellaneous_2428059704
source Wiley-Blackwell Read & Publish Collection
subjects adenovirus
Adenoviruses
Adolescent
Adult
bocavirus
Cadaver
Child
Child, Preschool
China - epidemiology
coinfection
Coinfection - epidemiology
Coinfection - mortality
Coinfection - virology
Coronaviruses
Cough
COVID-19
COVID-19 - epidemiology
Death
Female
Fever
human metapneumovirus
Humans
Infant
Infant, Newborn
Infections
Influenza
Influenza A
influenza virus
Influenza, Human - epidemiology
Iran - epidemiology
Male
Middle Aged
Mortality
Orthomyxoviridae - isolation & purification
Pandemics
Parainfluenza
parainfluenza virus
Pharyngitis
Polymerase chain reaction
Prevalence
Public health
Respiratory diseases
Respiratory syncytial virus
Respiratory Syncytial Virus, Human - isolation & purification
Reverse transcription
SARS-CoV-2 - isolation & purification
SARS‐Cov‐2
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Viral diseases
Virology
Viruses
Viruses - classification
Viruses - isolation & purification
Young Adult
title High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A55%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20SARS%E2%80%90CoV%E2%80%902%20and%20influenza%20A%20virus%20(H1N1)%20coinfection%20in%20dead%20patients%20in%20Northeastern%20Iran&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Hashemi,%20Seyed%20A.&rft.date=2021-02&rft.volume=93&rft.issue=2&rft.spage=1008&rft.epage=1012&rft.pages=1008-1012&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.26364&rft_dat=%3Cproquest_cross%3E2428059704%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3884-1b0e3714f491ee1070c599744df8d87042b459e6db0dce49fb213cc6e1a87f803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2473800288&rft_id=info:pmid/32720703&rfr_iscdi=true